Long Noncoding RNAs as Biomarkers in Cancer

Article Properties
  • Language
    English
  • Publication Date
    2017/01/01
  • Journal
  • Indian UGC (Journal)
  • Refrences
    222
  • Citations
    251
  • Luka Bolha Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  • Metka Ravnik-Glavač Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia ORCID
  • Damjan Glavač Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia ORCID
Abstract
Cite
Bolha, Luka, et al. “Long Noncoding RNAs As Biomarkers in Cancer”. Disease Markers, vol. 2017, 2017, pp. 1-14, https://doi.org/10.1155/2017/7243968.
Bolha, L., Ravnik-Glavač, M., & Glavač, D. (2017). Long Noncoding RNAs as Biomarkers in Cancer. Disease Markers, 2017, 1-14. https://doi.org/10.1155/2017/7243968
Bolha L, Ravnik-Glavač M, Glavač D. Long Noncoding RNAs as Biomarkers in Cancer. Disease Markers. 2017;2017:1-14.
Refrences
Citations
Citations Analysis
The first research to cite this article was titled Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? and was published in 2017. The most recent citation comes from a 2024 study titled Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? . This article reached its peak citation in 2020 , with 52 citations.It has been cited in 139 different journals, 33% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 14 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year